Pharma-Bio Serv, Inc. (PBSV) › Cost of RevenuePharma-Bio Serv, Inc. (PBSV) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2017: $9.46M2018: $12.11M2019: $13.33M2020: $14.90M2021: $14.76M2022: $14.52M2023: $11.91M2024: $6.99M2025: $6.09M$6.09M2017Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$6.09M-12.9%2024$6.99M-41.3%2023$11.91M-18.0%2022$14.52M-1.6%2021$14.76M-1.0%2020$14.90M+11.8%2019$13.33M+10.1%2018$12.11M+28.1%2017$9.46M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share